Bafna Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/08/2026 ,inter alia, to consider and approve the Un-Audited Financial ....

BAFNA PHARMACEUTICALS LIMITED REGD. OFFICE: “BAFNA TOWERS”, NO.299, THAMBU CHETTY STREET, CHENNAI – 600001, TAMIL NADU, INDIA PHONE: 044-25267517/25270992/42677555, FAX: 91-44-25231264, Email: info@bafnapharma.com, Website: www.bafnapharma.com CIN: L24294TN1995PLCO30698 Date: August 05, 2026 BSE Limited, National Stock Exchange of India Limited, Phiroze Jeejeebhoy Towers, Exchange Plaza, Dalal Street, Bandra Kurla Complex, Mumbai - 400001. Bandra East, Mumbai – 400051. Scrip Code: 532989 Scrip Code: BAFNAPH Dear Sir/Madam, Subject: Intimation of Board Meeting under Regulation 29 of SEBI (LODR) Regulations, 2015. Pursuant to Regulation 29 of the SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015, We hereby inform you that a meeting of the Board of Directors of the Company is scheduled to be held on Tuesday, the August 11, 2026, inter-alia to consider and approve the Un-Audited Financial Results of the Company for the Quarter ended June 30, 2026. Further, in terms of the Company’s Code of Conduct for Prevention of Insider Trading, the Trading Window for dealing in the shares by the Designated Persons of the Company and their immediate relatives, remains closed from July 01, 2026 to August 13, 2026 (both days inclusive) for the purpose of considering the Un-Audited Financial Results of the Company for the Quarter ended June 30, 2026. We request you to take the information on record. Thanking You. For BAFNA PHARMACEUTICALS LIMITED Mohanachandran A Company Secretary & Compliance Officer Factory: No.147, Madhavaram Redhills High Road, Grantlyon Village, Vadakarai Post, Chennai-600 052, TN, India Phone: 9445149001 Email: factory1@bafnapharma.com